Laurion Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Laurion Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$499K	–	569
2022 Q3	$499K	Hold	50,000	–	–	﹤0.01%	398
2022 Q2	$494K	Hold	50,000	–	–	0.01%	332
2022 Q1	$491K	Hold	50,000	–	–	0.01%	348
2021 Q4	$488K	Hold	50,000	–	–	﹤0.01%	423
2021 Q3	$492K	Hold	50,000	–	–	﹤0.01%	572
2021 Q2	$488K	Buy	+50,000	New	+$493K	﹤0.01%	516

Laurion Capital Management's FLAC Position: Q4 2022 in Review

Laurion Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 50,000 shares — an estimated $499K sold.

Laurion Capital Management first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $499K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Laurion Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Laurion Capital Management sold 50,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $499K.
Laurion Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
Laurion Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $499K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.